Join The Advisor Team
More

Tag: Rare Disease

Mary Hames: Medical Affairs Executive with Expertise in Rare Disease and Launch Strategy

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.

Ben Kozub: Pushing Boundaries, Redefining Success; There is No Finish Line.

Excited to share my professional biography, highlighting my journey in global strategy, product launches, and commercialization within the pharmaceutical and biotech sectors. With over 25 years of experience, I've had the opportunity to work with extraordinary teams, driving growth and innovation across complex therapeutic areas. Here is my biography.